(E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1

Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann et al. · New England Journal of Medicine · 2005 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Decreased extra-renal urate excretion is a common cause of hyperuricemia

Kimiyoshi Ichida, Hirotaka Matsuo, Tappei Takada et al. · Nature Communications · 2012 · 691 citations · Full text

Medicine, Nephrology, Physiology +11

Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice

Gang Chen, Ming‐Liang Tan, Kai-Kai Li et al. · Journal of Ethnopharmacology · 2015 · 130 citations

Medicine, Biochemistry, Pharmacology +14

The Dual Actions of Morin (3,5,7,2′,4′-Pentahydroxyflavone) as a Hypouricemic Agent: Uricosuric Effect and Xanthine Oxidase Inhibitory Activity

Zhifeng Yu, Wing Ping Fong, Christopher H.K. Cheng · Journal of Pharmacology and Experimental Therapeutics · 2005 · 129 citations

Medicine, Botany, Pharmacology +16

Interactions of urate transporter URAT1 in human kidney with uricosuric drugs

Ho Jung Shin, Michio Takeda, Atsushi Enomoto et al. · Nephrology · 2010 · 115 citations

Pharmacy, Biochemistry, Pharmacology +17